<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02737917</url>
  </required_header>
  <id_info>
    <org_study_id>IRB #16-003</org_study_id>
    <nct_id>NCT02737917</nct_id>
  </id_info>
  <brief_title>EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation</brief_title>
  <acronym>ENDAO</acronym>
  <official_title>EmergeNcy Department Apneic Oxygenation Versus Usual Care During Rapid Sequence Intubation : A Randomized Controlled Trial (The ENDAO Trial)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York City Health and Hospitals Corporation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York City Health and Hospitals Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the impact, if any the application of oxygen during the apnea period of rapid
      sequence intubation has on patients being intubated in the emergency department.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypoxia may occur during rapid sequence intubation (RSI) of emergency department patients
      (1-4). This condition may increase the risk of the patient suffering a cardiac arrest
      secondary to securing the airway. A part of RSI is pre-oxygenation, which is defined as
      placing the patient on 100% fraction of inspired O2 for 3 minutes prior to administering the
      induction agents (i.e. sedative and neuromuscular blocker) in order to increase the amount of
      oxygen present in the functional residual capacity of the patients lungs to prolong oxygen
      saturating during the apneic period of endotracheal intubation (5-9). In the last decade,
      physicians have developed a process known as diffuse apneic oxygenation (DAO) in order to
      mitigate the risk of oxygen desaturation during this apneic period. The process entails
      leaving the patient on high flow nasal cannula (HFNC) oxygen during the act of visualizing
      the vocal cords and placing the endotracheal tube. Over the years the practice has started to
      become more common in emergency departments, operating rooms and ICU's all over the world.
      Recently, a randomized controlled trial (called The FELLOW Trial) of this practice
      demonstrated no difference in desaturation rates between those patients that received DAO and
      those that did not (usual practice) in patients in the ICU (10). Some have commented that the
      findings of this study cannot be applied to emergency department patients, and so evidence is
      lacking in regards to this population.

      Purpose of the study:

      Although studies have started to investigate the efficacy of DAO in preventing desaturation
      during RSI, evidence is still lacking in the emergency department patient population. The
      primary question being asked is: does diffuse apneic oxygenation increase the average lowest
      arterial oxygen saturation during rapid sequence intubation when compared to usual care?
      Secondary question being asked is: does diffuse apneic oxygenation decrease the incidence of
      desaturation in general, as well as hypoxemia and severe hypoxemia? The third question being
      asked is: does diffuse apneic oxygenation increase the time to desaturation?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">December 2016</completion_date>
  <primary_completion_date type="Actual">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean (Average) Arterial Oxygen Saturation</measure>
    <time_frame>within 2 minutes of confirmation of endotracheal tube placement</time_frame>
    <description>the average oxygen saturation as measured by peripheral capillary oxygen saturation (SpO2)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rates of Desaturation</measure>
    <time_frame>within 2 minutes of confirmation of endotracheal tube placement</time_frame>
    <description>number of patients per group that desaturated to less than 90% and less than 80%</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">206</enrollment>
  <condition>Diffuse Apneic Oxygenation</condition>
  <arm_group>
    <arm_group_label>Diffuse apneic oxygenation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxygen</intervention_name>
    <description>15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.</description>
    <arm_group_label>Diffuse apneic oxygenation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard of care</intervention_name>
    <description>Rapid sequence intubation</description>
    <arm_group_label>Diffuse apneic oxygenation</arm_group_label>
    <arm_group_label>Usual care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Any patient greater than 18 years of age that presents to the Lincoln medical and Mental
        Health Center Emergency Department requiring endotracheal intubation.

        Exclusion Criteria:

        Patients will be excluded from the primary outcome analysis, but included in the intention
        to treat analysis for the secondary outcome if they are not pre-oxygenated to the standard
        RSI protocol of 3 minutes with 100% fraction of inspired oxygen (FiO2) by means of bag
        valve mask, HFNC and/or non-rebreather; patients will be excluded from the study in general
        if they are in cardiac or traumatic arrest or they are intubated without an apneic period
        (awake intubation)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sandra Scott, MD</last_name>
    <role>Study Chair</role>
    <affiliation>NYCHHC/Lincoln</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Lincoln Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10451</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jaber S, Amraoui J, Lefrant JY, Arich C, Cohendy R, Landreau L, Calvet Y, Capdevila X, Mahamat A, Eledjam JJ. Clinical practice and risk factors for immediate complications of endotracheal intubation in the intensive care unit: a prospective, multiple-center study. Crit Care Med. 2006 Sep;34(9):2355-61.</citation>
    <PMID>16850003</PMID>
  </reference>
  <reference>
    <citation>Griesdale DE, Bosma TL, Kurth T, Isac G, Chittock DR. Complications of endotracheal intubation in the critically ill. Intensive Care Med. 2008 Oct;34(10):1835-42. doi: 10.1007/s00134-008-1205-6. Epub 2008 Jul 5.</citation>
    <PMID>18604519</PMID>
  </reference>
  <reference>
    <citation>Simpson GD, Ross MJ, McKeown DW, Ray DC. Tracheal intubation in the critically ill: a multi-centre national study of practice and complications. Br J Anaesth. 2012 May;108(5):792-9. doi: 10.1093/bja/aer504. Epub 2012 Feb 6.</citation>
    <PMID>22315326</PMID>
  </reference>
  <reference>
    <citation>De Jong A, Molinari N, Terzi N, Mongardon N, Arnal JM, Guitton C, Allaouchiche B, Paugam-Burtz C, Constantin JM, Lefrant JY, Leone M, Papazian L, Asehnoune K, Maziers N, Azoulay E, Pradel G, Jung B, Jaber S; AzuRéa Network for the Frida-Réa Study Group. Early identification of patients at risk for difficult intubation in the intensive care unit: development and validation of the MACOCHA score in a multicenter cohort study. Am J Respir Crit Care Med. 2013 Apr 15;187(8):832-9. doi: 10.1164/rccm.201210-1851OC.</citation>
    <PMID>23348979</PMID>
  </reference>
  <reference>
    <citation>Baillard C, Fosse JP, Sebbane M, Chanques G, Vincent F, Courouble P, Cohen Y, Eledjam JJ, Adnet F, Jaber S. Noninvasive ventilation improves preoxygenation before intubation of hypoxic patients. Am J Respir Crit Care Med. 2006 Jul 15;174(2):171-7. Epub 2006 Apr 20.</citation>
    <PMID>16627862</PMID>
  </reference>
  <reference>
    <citation>Mort TC. Preoxygenation in critically ill patients requiring emergency tracheal intubation. Crit Care Med. 2005 Nov;33(11):2672-5.</citation>
    <PMID>16276196</PMID>
  </reference>
  <reference>
    <citation>Mort TC, Waberski BH, Clive J. Extending the preoxygenation period from 4 to 8 mins in critically ill patients undergoing emergency intubation. Crit Care Med. 2009 Jan;37(1):68-71. doi: 10.1097/CCM.0b013e318192845e.</citation>
    <PMID>19050620</PMID>
  </reference>
  <reference>
    <citation>Vourc'h M, Asfar P, Volteau C, Bachoumas K, Clavieras N, Egreteau PY, Asehnoune K, Mercat A, Reignier J, Jaber S, Prat G, Roquilly A, Brule N, Villers D, Bretonniere C, Guitton C. High-flow nasal cannula oxygen during endotracheal intubation in hypoxemic patients: a randomized controlled clinical trial. Intensive Care Med. 2015 Sep;41(9):1538-48. doi: 10.1007/s00134-015-3796-z. Epub 2015 Apr 14.</citation>
    <PMID>25869405</PMID>
  </reference>
  <reference>
    <citation>Weingart SD, Levitan RM. Preoxygenation and prevention of desaturation during emergency airway management. Ann Emerg Med. 2012 Mar;59(3):165-75.e1. doi: 10.1016/j.annemergmed.2011.10.002. Epub 2011 Nov 3. Review.</citation>
    <PMID>22050948</PMID>
  </reference>
  <reference>
    <citation>Semler MW, Janz DR, Lentz RJ, Matthews DT, Norman BC, Assad TR, Keriwala RD, Ferrell BA, Noto MJ, McKown AC, Kocurek EG, Warren MA, Huerta LE, Rice TW; FELLOW Investigators; Pragmatic Critical Care Research Group. Randomized Trial of Apneic Oxygenation during Endotracheal Intubation of the Critically Ill. Am J Respir Crit Care Med. 2016 Feb 1;193(3):273-80. doi: 10.1164/rccm.201507-1294OC.</citation>
    <PMID>26426458</PMID>
  </reference>
  <reference>
    <citation>Ramachandran SK, Cosnowski A, Shanks A, Turner CR. Apneic oxygenation during prolonged laryngoscopy in obese patients: a randomized, controlled trial of nasal oxygen administration. J Clin Anesth. 2010 May;22(3):164-8. doi: 10.1016/j.jclinane.2009.05.006.</citation>
    <PMID>20400000</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>April 5, 2016</study_first_submitted>
  <study_first_submitted_qc>April 13, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 14, 2016</study_first_posted>
  <results_first_submitted>August 18, 2017</results_first_submitted>
  <results_first_submitted_qc>November 2, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">March 4, 2019</results_first_posted>
  <last_update_submitted>March 4, 2019</last_update_submitted>
  <last_update_submitted_qc>March 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>No plan to make individual participant data available</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Apneic Oxygenation</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.
Oxygen: 15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.
Standard of care: Rapid sequence intubation</description>
        </group>
        <group group_id="P2">
          <title>Usual Care</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)
Standard of care: Rapid sequence intubation</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="103"/>
                <participants group_id="P2" count="103"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="100"/>
                <participants group_id="P2" count="100"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Apneic Oxygenation</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.
Oxygen: 15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.
Standard of care: Rapid sequence intubation</description>
        </group>
        <group group_id="B2">
          <title>Usual Care</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)
Standard of care: Rapid sequence intubation</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="100"/>
            <count group_id="B2" value="100"/>
            <count group_id="B3" value="200"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="54.2" lower_limit="21" upper_limit="89"/>
                    <measurement group_id="B2" value="55.1" lower_limit="22" upper_limit="93"/>
                    <measurement group_id="B3" value="54.7" lower_limit="21" upper_limit="93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="58"/>
                    <measurement group_id="B2" value="59"/>
                    <measurement group_id="B3" value="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="100"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="200"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>American Society of Anesthesia Classification</title>
          <description>The American Society of Anesthesia Classification is a scale system for assessing the fitness of patients before receiving anesthesia. Class 1 is a healthy person; Class 2 is mild systemic disease; Class 3 is severe systemic disease; Class 4 is Severe systemic disease that is a constant threat to life. 1 is the best and 4 is the worst.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.67" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B2" value="2.69" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B3" value="2.68" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cormack-Lehane Grade/Scale of View</title>
          <description>The Cormack-Lehane Grade View is a scale from 1 to 4 (1,2,3,4) that numerical represent the view of the vocal cords during intubation. A lower number equates to the better view (i.e. 1=full view of the vocal cords) and higher numbers a worse view (i.e. 4=no view of the vocal cords).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.41" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B2" value="1.48" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="B3" value="1.44" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean (Average) Arterial Oxygen Saturation</title>
        <description>the average oxygen saturation as measured by peripheral capillary oxygen saturation (SpO2)</description>
        <time_frame>within 2 minutes of confirmation of endotracheal tube placement</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Apneic Oxygenation</title>
            <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.
Oxygen: 15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.
Standard of care: Rapid sequence intubation</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)
Standard of care: Rapid sequence intubation</description>
          </group>
        </group_list>
        <measure>
          <title>Mean (Average) Arterial Oxygen Saturation</title>
          <description>the average oxygen saturation as measured by peripheral capillary oxygen saturation (SpO2)</description>
          <units>Percent Saturation (SpO2)</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="92" lower_limit="91" upper_limit="93"/>
                    <measurement group_id="O2" value="93" lower_limit="92" upper_limit="94"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rates of Desaturation</title>
        <description>number of patients per group that desaturated to less than 90% and less than 80%</description>
        <time_frame>within 2 minutes of confirmation of endotracheal tube placement</time_frame>
        <population>All patients undergoing rapid sequence intubation receiving either Apneic Oxygenation or Usual Care</population>
        <group_list>
          <group group_id="O1">
            <title>Apneic Oxygenation</title>
            <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.
Oxygen: 15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.
Standard of care: Rapid sequence intubation</description>
          </group>
          <group group_id="O2">
            <title>Usual Care</title>
            <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)
Standard of care: Rapid sequence intubation</description>
          </group>
        </group_list>
        <measure>
          <title>Rates of Desaturation</title>
          <description>number of patients per group that desaturated to less than 90% and less than 80%</description>
          <population>All patients undergoing rapid sequence intubation receiving either Apneic Oxygenation or Usual Care</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="100"/>
                <count group_id="O2" value="100"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Desaturation &gt;=80%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Desaturation &lt;80%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>No Desaturation to &lt;90% or 80%</title>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days</time_frame>
      <desc>Serious adverse events (peri-intubation cardiac arrest, bradycardia) are related to hypoxemia during endotracheal intubation in general but not known to occur due to the administration of supplemental oxygen during such procedure.</desc>
      <group_list>
        <group group_id="E1">
          <title>Apneic Oxygenation</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation) plus the application of oxygen.
Oxygen: 15 L of oxygen will be delivered to the patient by nasal cannula during the apnea period of rapid sequence intubation.
Standard of care: Rapid sequence intubation</description>
        </group>
        <group group_id="E2">
          <title>Usual Care</title>
          <description>This group of patients will receive the standard of care treatment of rapid sequence intubation (pre-oxygenation, induction and intubation)
Standard of care: Rapid sequence intubation</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="16" subjects_at_risk="100"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="100"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="100"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Nicholas Caputo</name_or_title>
      <organization>Lincoln Medical Center</organization>
      <phone>718-579-6010</phone>
      <email>ncaputo.md@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

